期刊文献+

血清骨保护素和脑利钠肽水平与非ST段抬高型急性冠状动脉综合征患者冠状动脉病变程度的相关性 被引量:5

The Relationship Between Osteoprotegerin and Brain Natriuretic Peptide Levels and Degree of Coronary Disease in Patients with non-ST Elevation Acute Coronary Syndrome
下载PDF
导出
摘要 目的探讨血清骨保护素和脑利钠肽水平与非ST段抬高急性冠状动脉综合征患者冠状动脉病变程度之间的关系。方法 192例受试者分为三组:稳定型心绞痛患者58例,不稳定型心绞痛/非ST段抬高心肌梗死患者99例,对照者35例,入院时检测血清骨保护素和脑利钠肽水平,并进行冠状动脉造影。根据造影结果对冠状动脉病变进行Gensini评分,分析两种标志物与冠状动脉狭窄数及冠状动脉病变Gensini评分的相关性。结果所有冠心病患者骨保护素水平高于对照组(P<0.01),稳定型心绞痛组骨保护素水平低于不稳定型心绞痛/非ST段抬高心肌梗死组(P<0.01);稳定型心绞痛组脑利钠肽水平略高于对照组(P>0.05),不稳定型心绞痛/非ST段抬高心肌梗死组脑利钠肽水平明显高于稳定型心绞痛组(P<0.01);多支血管病变患者脑利钠肽水平显著高于单支血管病变患者(P<0.01),脑利钠肽与冠状动脉病变Gensini评分轻微相关(r=0.45,P<0.01),骨保护素与冠状动脉病变Gensini评分显著相关(r=0.64,P<0.001),多元回归分析发现骨保护素和脑利钠肽与冠心病独立相关(P<0.01)。结论血清骨保护素与不稳定型心绞痛/非ST段抬高心肌梗死患者冠状动脉狭窄程度及病变进展有关,提示骨保护素可能参与了冠状动脉疾病的进程。不稳定型心绞痛/非ST段抬高心肌梗死患者脑利钠肽水平也增高,表明脑利钠肽水平与缺血范围以及严重程度有较大的关联。 Aim To analyse osteoprotegerin(OPG) and brain natriuretic peptide(BNP) levels in patients with non-ST elevation acute coronary syndrome(NSTE-ACS),in relation to clinical presentation and to coronary coronary artery disease. Methods 192 consecutive patients were classified into three groups: stable angina(SA) group,unstable angina/non-ST elevation myocardial infarction(NSTE-ACS) group and control group,OPG and BNP levels were measured.OPG and BNP were compared in relation to the number of coronary artery disease,and to the stenoses degree by Gensini score. Results OPG levels were higher in all coronary artery disease patients compared to controls(P〈0.01),however NSTE-ACS patients had higher OPG level with respect to SA patients(P〈0.01).BNP levels were higher in NSTE-ACS patients compared to controls and SA patients(P〈0.01).BNP levels was significantly higher in multivessels compared with 1-vessel disease(P〈0.01).A positive relation was found between OPG levels and Gensini score(r=0.64,P〈0.001).Only a mild correlation was found between BNP and Gensini score(r=0.45,P〈0.01).Multiple regression analysis showed that OPG and BNP levels were independently and positively associated with the presence of coronary disease(P〈0.01). Conclusions NSTE-ACS patients show high OPG levels.OPG is related to the number of coronary artery disease,which suggest its involvement in the coronary artery disease progression.BNP is also increased during NSTE-ACS and more associated to the scope and severity of ischemia.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2010年第8期655-657,共3页 Chinese Journal of Arteriosclerosis
基金 军队医学科技创新项目资助(09MA094)
关键词 非ST段抬高急性冠状动脉综合征 冠状动脉病变程度 骨保护素 脑利钠肽 non-ST Elevation Acute Coronary Syndromes Coronary Artery Disease Extension Osteoprotegerin Brain Natriuretic Peptide
  • 相关文献

参考文献10

  • 1de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B- type natriuretic peptide in patients with acute coronary syndromes [ J ]. N Engl J Med, 2001,345:1 014-021.
  • 2Sadanandan S, Cannon CP, Chekuri K, et al. Association of elevated B- type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction [ J ]. J Am Coil Cardiol, 2004, 44: 564-568.
  • 3Kiechl S, Schett G, Wenning G, et al. Osteoprotegerin is a risk factor for progressive atherosclerasis and cardiovascular disease [ J ]. Circulation, 2004, 109:2 175-180.
  • 4Jono S, Shioi A, Ikari Y, et al. Vascular calcification in chronic kidney disease[J].J Bone Miner Metab, 2006, 24: 176-181.
  • 5Morrow DA, de Lemos J, Sabatine M, et al. Evaluation of B-type natriuretie peptide for risk assessment in unstable angina/non ST-elevation myo- cardial infarction [J]. JAm Coll Cardiol, 2003, 41:1 264-272.
  • 6Bazzino O, Fuseni J J, Botto F, et al. PACS group of investigators. Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/ AHA prognostic classification and other risk markers in patients with non-ST elevation coronary syndromes [ J ]. Eur Heart J, 2004, 25: 859-866.
  • 7Jono S, IkariY, ShioiA, et al. Serum osteoprotegerin levels are associatedwith the presence and severity of coronary artery disease [ J ]. Circulation, 2002, 106:1 192-194.
  • 8Schoppet M, Sattler AM, Schaefer JR, et al. Increased osteoprotegerin serum levels in men with coronary artery disease [ J ]. J Clin Endocrinol Metab, 2003, 88 : 1 024-028.
  • 9Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease [ J ]. Am J Cardiol, 1983, 51 (3) : 606- 609.
  • 10Avignon A, Sultan A, Piot C, et al. Osteoprotegerin is associated with silent coronmy artery disease in high-risk but asymptomatic type 2 diabetic patients [ J]. Diabetes Care, 2005, 28:2 176-180.

同被引文献95

  • 1高琪乐,余国龙,何玲玲,裴志芳.血浆脑钠肽动态变化对急性左心衰患者院内预后的预测价值[J].中国实用内科杂志,2009,29(S1):12-14. 被引量:1
  • 2刘晓田.克林澳治疗急性脑梗死85例[J].吉林医学,2013,34(13):2492-2493. 被引量:2
  • 3崔喜梅,卫国红,荆小莉,廖晓星,李欣,熊艳,王西富.N末端脑钠肽对急性呼吸困难的鉴别诊断价值[J].中国急救医学,2007,27(7):601-602. 被引量:27
  • 4赵昕,王萌.N端脑钠肽前体对心力衰竭诊断价值的研究[J].中国老年学杂志,2007,27(13):1287-1289. 被引量:51
  • 5Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel se-creted protein involved in the regulation of bone density [J]. Cell,1997,89(2):309-319.
  • 6Blair JM, Zheng Y, Dunstan CR. RANK ligand [J]. lnt J Biochem Cell Biol,2007,39(6):1 077-081.
  • 7Fan X, Roy E, Zhu L, et al. Nitric oxide regulates receptor activator of nuclear factor-kappaB ligand and osteoprotegefin expression in bone marrow stromal cells [J]. Endocrinology,2004,145(2):751-759.
  • 8Bergh JJ, Yihuan Xu, Mary C, et al. Osteoprotegerin expression and se2 cretion is regulated by calcium influx through the L-type voltage sensitive calcium channel [J]. Endocrinology,2004,145 (1):426-.436.
  • 9Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegrin/osteoclastogenesisinhibitory factor and is identi-cal to TRANCE/KANKL [J]. ProcNatlAcadSciUSA,1998,95(7):3 597-602.
  • 10Abedin M, Omland T, Ueland T, et al. Relation of osteoprptegerin tocoronary calcium and aortic plaque (from the Dallas Heart Study) [J]. Am J Cardiol,2007,99(4):513-518.

引证文献5

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部